NCT07837973

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-08-10Est. Completion: 2027-08-24

Enrollment target: 220 participants

Locations

University of Alabama - Birmingham, Birmingham, Alabama, United States
DM Clinical Research, Sun City, Arizona, United States
AMR Clinical, Tempe, Arizona, United States
Profound Research, Oceanside, California, United States
DM Clinical Research, Bradenton, Florida, United States
DM Clinical Research, Doral, Florida, United States
Clinical Neuroscience Solutions, Orlando, Florida, United States
North Georgia Clinical Research, Woodstock, Georgia, United States
Christie Clinic, Champaign, Illinois, United States
BRCR Global Louisiana, Gretna, Louisiana, United States
Profound Research, Farmington Hills, Michigan, United States
ALSA Research-Manhattan, New York, New York, United States
TMA Headlands, Wilmington, North Carolina, United States
Lynn Health Science Institute, Oklahoma City, Oklahoma, United States
AMR Clinical, Nashville, Tennessee, United States
DM Clinical Research, Irving, Texas, United States
DM Clinical Research - Dominion Family Healthcare, San Antonio, Texas, United States

Class I/II Obesity

The goal of this clinical trial is to learn about the nature of brain abnormalities associated with excess body fat in h…

Montreal, CanadaEst. completion Dec 1, 2028

Healthy VolunteerObestity

Background: Many people in the United States are overweight or obese. This natural history study will look into how lif…

Phoenix, United StatesEst. completion Jan 30, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.